The FDA initially approved the drug in 2014 as ... with heart failure across the spectrum of ejection fraction," said Javed Butler, M.D, chairman, Department of Medicine, University of Mississippi.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results